Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Primary Hyperparathyroidism with Denosumab and Cinacalcet
2016-001510-20Phase 4Completed
- Sponsor
- Aalborg University Hospital
- Start
- May 2016
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in primary hyperparathyroidism (PHPT), osteoporosis and osteopenia comparing Denosumab, Denosumab + Cinacalcet and Placebo/Control (3 arms). Primary endpoint: Change in bone mineral density after one year. Started May 2016; status: completed.
02
Drugs
denosumabcinacalcet
03
Conditions
primary hyperparathyroidism (PHPT)osteoporosisosteopenia
Beyond the preview
Go deeper on 2016-001510-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001510-20.